…
Chill Brands Group PLC engages in the research and development, production, and sale of cannabidiol consumer products and other lifestyle goods in the United States, the United Kingdom, and rest of Europe. It offers tobacco alternative products, including CBD-infused oral chew pouches and herbal smokes. The company also provides CBD-infused topical creams, beauty products, and ingestible tinctures, as well as nicotine-free vapour products. It serves its products under the Chill.com, Zoetic, and Chill Zero brands. The company was formerly known as Zoetic International Plc and changed its name to Chill Brands Group PLC in August 2021. Chill Brands Group PLC was incorporated in 2014 and is based in London, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Income before tax | -4.26M | -5.57M | -5.90M | -1.85M | -5.77M |
| Net income | -4.29M | -5.71M | -5.95M | -7.08M | -5.77M |
| Selling general administrative | 2.64M | 2.84M | 4.66M | 1.88M | 5.51M |
| Selling and marketing expenses | 1.13M | - | - | - | - |
| Gross profit | -0.21M | -0.78M | -0.04M | 0.04M | 0.69M |
| Reconciled depreciation | 0.13M | 0.11M | 0.02M | 0.33M | 0.32M |
| Ebit | -3.94M | -5.57M | -4.80M | -2.95M | -3.22M |
| Ebitda | -3.81M | -5.46M | -4.78M | -2.62M | -2.89M |
| Depreciation and amortization | 0.13M | 0.11M | 0.02M | 0.33M | 0.32M |
| Operating income | -4.12M | -5.57M | -5.90M | -1.85M | -4.50M |
| Other operating expenses | 4.20M | 6.20M | 6.22M | 1.94M | 5.51M |
| Interest expense | 0.32M | 0.00M | 0.00M | 0.00M | 0.00M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | 0.02M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | -0.30M | 0.00M | 0.00M | 0.00M | 0.00M |
| Income tax expense | 0.20M | 0.14M | 0.05M | 5.23M | 1.28M |
| Total revenue | 0.08M | 0.62M | 0.32M | 0.09M | 1.02M |
| Total operating expenses | 3.91M | 4.80M | 5.86M | 1.88M | 5.51M |
| Cost of revenue | 0.29M | 1.40M | 0.36M | 0.06M | 0.32M |
| Total other income expense net | -0.15M | 0.00M | 0.00M | 1.10M | -1.28M |
| Discontinued operations | -0.02M | -0.14M | -0.05M | -5.23M | -5.14M |
| Net income from continuing ops | -4.26M | -5.57M | -4.80M | -1.85M | -5.77M |
| Net income applicable to common shares | - | -5.71M | -4.85M | -8.18M | -5.77M |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Total assets | 6.14M | 3.26M | 1.76M | 3.34M | 7.63M |
| Intangible assets | 1.21M | 1.19M | - | - | 0.44M |
| Other current assets | - | - | - | 0.30M | - |
| Total liab | 5.26M | 1.72M | 1.99M | 1.23M | 1.31M |
| Total stockholder equity | 0.88M | 1.54M | -0.22M | 2.11M | 6.32M |
| Other current liab | - | 0.61M | 1.20M | - | - |
| Common stock | 2.61M | 2.12M | 2.02M | 1.73M | 1.36M |
| Capital stock | 2.61M | 2.12M | 2.02M | 1.73M | 1.36M |
| Retained earnings | -18.91M | -14.62M | -8.91M | -4.09M | 3.31M |
| Cash | 3.77M | 0.42M | 0.33M | 0.35M | 1.51M |
| Total current liabilities | 1.08M | 1.47M | 1.91M | 1.23M | 1.31M |
| Net debt | 0.74M | - | - | 0.24M | - |
| Short long term debt | 0.47M | 0.02M | 0.01M | 0.59M | - |
| Other stockholder equity | 6.25M | 3.74M | 1.96M | 1.45M | 0.37M |
| Property plant equipment | 0.25M | 0.31M | 0.05M | 0.08M | 1.50M |
| Total current assets | 4.68M | 1.76M | 1.71M | 3.26M | 2.70M |
| Net tangible assets | - | 0.35M | -0.22M | 2.11M | 2.88M |
| Net receivables | 0.45M | 0.61M | 0.06M | 1.41M | 0.58M |
| Long term debt | 4.03M | 0.05M | 0.07M | - | - |
| Inventory | 0.46M | 0.64M | 1.24M | 1.17M | - |
| Accounts payable | 0.42M | 0.73M | 0.66M | 0.11M | 0.15M |
| Non current assets total | 1.46M | 1.50M | 0.05M | 0.08M | 4.94M |
| Capital lease obligations | 0.22M | 0.27M | - | - | - |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Investments | -0.64M | -0.64M | 0.30M | -0.16M | 2.79M |
| Change to liabilities | 0.00M | 0.07M | -0.24M | -0.42M | -1.40M |
| Total cashflows from investing activities | - | -0.64M | 0.30M | -0.16M | 2.79M |
| Net borrowings | 4.61M | -0.06M | 0.08M | -0.86M | -0.86M |
| Total cash from financing activities | 6.61M | 5.64M | 0.62M | 1.25M | 1.66M |
| Change to operating activities | - | -1.20M | 1.24M | 1.24M | 1.24M |
| Net income | -4.29M | -5.71M | -5.95M | -7.08M | -5.77M |
| Change in cash | 3.35M | 0.09M | -0.02M | -1.16M | 0.91M |
| Begin period cash flow | 0.42M | 0.33M | 0.35M | 1.51M | 0.60M |
| End period cash flow | 3.77M | 0.42M | 0.33M | 0.35M | 1.51M |
| Total cash from operating activities | -2.51M | -4.96M | -0.98M | -2.26M | -3.57M |
| Issuance of capital stock | 2.00M | 5.70M | 0.54M | 2.11M | 1.66M |
| Depreciation | 0.13M | 0.11M | 0.02M | 0.33M | 0.32M |
| Change to inventory | -0.03M | -0.06M | -0.28M | -1.17M | -1.17M |
| Change to account receivables | 0.29M | -0.56M | 1.30M | 0.94M | 1.35M |
| Other cashflows from financing activities | 2.00M | -0.05M | 0.30M | -0.16M | 2.79M |
| Change to netincome | 1.62M | 2.39M | 1.81M | 6.23M | 1.93M |
| Capital expenditures | 0.64M | 0.64M | 0.00M | 0.16M | 1.45M |
| Change in working capital | 0.02M | -1.76M | 2.03M | -0.64M | -0.05M |
| Stock based compensation | 1.17M | 2.05M | 1.41M | 1.14M | 0.00M |
| Other non cash items | 0.45M | 0.09M | 0.40M | 5.10M | 1.93M |
| Free cash flow | -3.15M | -5.61M | -0.99M | -2.42M | -5.02M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MKKGY Merck KGaA ADR |
0.03 0.09% |
33.71 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
-0.54 0.32% |
168.71 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
- -% |
20.87 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
4.63 12.39% |
42.00 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
Chill Brands Group PLC engages in the research and development, production, and sale of cannabidiol consumer products and other lifestyle goods in the United States, the United Kingdom, and rest of Europe. It offers tobacco alternative products, including CBD-infused oral chew pouches and herbal smokes. The company also provides CBD-infused topical creams, beauty products, and ingestible tinctures, as well as nicotine-free vapour products. It serves its products under the Chill.com, Zoetic, and Chill Zero brands. The company was formerly known as Zoetic International Plc and changed its name to Chill Brands Group PLC in August 2021. Chill Brands Group PLC was incorporated in 2014 and is based in London, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Trevor Taylor | Founder, COO & Exec. Director | NA |
| Mr. Antonio Russo | Founder, Chief Commercial Officer & Exec. Director | NA |
| Mr. Callum Sommerton | CEO & Exec. Director | NA |
| Mr. Paul Ferguson | CFO & Director | NA |
| Mr. Will Aspinwall | Internal Counsel and Bus. Devel. | NA |
| Mr. Graham John William Duncan | Finance Director & Director | 1963 |
| Mr. Will Aspinwall | Internal Counsel and Business Development | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.